---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-028356"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2025-05-29T23:59:59+00:00"
generated_at: "2026-05-20T05:57:55.482846+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology stockholders elect directors, approve executive pay, ratify auditor at 2025 annual meeting

## Summary
- Jeffrey S. Hatfield and Saira Ramasastry elected as Class III directors each with >93 million votes for.
- Advisory vote on executive compensation approved: 100.5 million for, 4.3 million against.
- Ernst & Young LLP ratified as independent auditor for FY 2025 (116.3 million for).
- All three proposals passed; no material change in governance or operations.

## SEC filing metadata
- accession: 0001628280-25-028356
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2025-05-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000162828025028356/0001628280-25-028356-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000162828025028356/vir-20250529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-028356
- JSON: https://secwatch.observer/filing/0001628280-25-028356.json
- Plain text: https://secwatch.observer/filing/0001628280-25-028356.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.